Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Paul Lévesque Insider Profile
4 Followers
Paul Lévesque, President & Chief Executive Officer at Theratechnologies, holds 72.80K shares in Theratechnologies (Ticker: THTX). Most recently, Paul Lévesque Bought $45,000 shares of Theratechnologies on Oct 31, 2023 for an estimated value of 61.20K.
Paul Lévesque has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
President & Chief Executive Officer
Roles that Paul Lévesque holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Paul Lévesque
Paul Lévesque's Trading History
List of latest transactions for each holding click on a transaction to see Paul Lévesque's performance on stock
You May Also Like
Paul Lévesque insider profile FAQ
What is the percentage of profitable transactions made by Paul Lévesque?
The percentage of profitable transactions made by Paul Lévesque is ―.
What is the average return per transaction made by Paul Lévesque?
The average return per transaction made by Paul Lévesque is ―.
What stocks does Paul Lévesque hold?
Paul Lévesque holds: THTX stocks.
What was Paul Lévesque’s latest transaction?
Paul Lévesque latest transaction was an Informative Buy of $61.20K.
What was Paul Lévesque's most profitable transaction?
Paul Lévesque’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Paul Lévesque's role in Theratechnologies?
Paul Lévesque's role in Theratechnologies is President & Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.